Zhang, Hongling
Liu, Qiang
Peng, Jinshan
Chen, Xizhe
Liu, Mouying
Chen, Yun
Wei, Sican
Huang, Minglian
Huang, Ling
Liao, Yanjun
Chen, Weiwen
Lin, Tianlai
Wu, Xiaodan
Funding for this research was provided by:
Natural Science Foundation of Fujian Province (No. 2023J011779)
Natural Science Foundation of Fujian Province (No. 2023J011769)
Science and Technology Planning Project of Quanzhou (No. 2024NY018)
Health and Healthcare Science and Technology Program of Fujian Province (No. 2024GGB14)
Article History
Received: 4 September 2025
Accepted: 29 December 2025
First Online: 3 January 2026
Declarations
:
: The authors declare no competing interests.
: All authors provided consent to the publication of this manuscript. Participants provided consent for the publication of anonymized data collected from the study.
: The animal experiment was reported in accordance with the ARRIVE guidelines and was approved by the Experimental Animal Ethics Committee of Quanzhou Medical College (No. 2024065). All methods were performed in accordance with the relevant guidelines and regulations. The clinical trial adhered strictly to the CONSORT guidelines and the principles of the Declaration of Helsinki, received approval from the Ethics Committee of Quanzhou First Hospital Affiliated to Fujian Medical University (No. QYL [2023] K056) and was first registered in the China Medical Research Registration and Filing Information System on 28/03/2024 (Registration Number: MR-35-24-017311).